Logo

Genome Therapeutics Achieves Milestone in Schering-Plough Research

Dec 31, 1999
Premium

W

ALTHAM, Mass.--Genome Therapeutics last month announced that it had reached a milestone in its genomics alliance with Schering-Plough. The genomics company is using its proprietary bioinformatics tools and high-throughput sequencing capacity to identify within a specific chromosomal region candidate genes believed to be involved in the development of asthma. The milestone achievement triggers a payment of an undisclosed amount by Schering to Genome Therapeutics.

Filed under

Informatics
Breaking News
The Scan

For Those Thick Tiger Stripes

Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports.

High GABA Tomatoes

The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan.

Approach for Inclusivity and Diversity

A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos."

Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation

In Science this week: study of how tumors evade the adaptive immune system, and more.